Vertex Pharmaceuticals | VRTX - Eps Ganancias Por Acción

Precio De Mercado
430.29
Cambio Diario
-4.81 -1.11%
Mensual
-5.42%
Anual
-12.87%
Q2 Expectativa
421.08

Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q1 Mar/2026 4.43 4.06 May/04
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03
FY2025Q2 Jun/2025 4.52 4.32 -12.83 Aug/04
FY2025Q1 Mar/2025 4.06 4.27 4.76 May/05




Eps Cambio Fecha
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
J&J USD 2.7 0.24 2026-03
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12